September 16-18, 2025
Hynes Convention CenterBoston, MA Daniel FriedmanPrincipal at BroadOak CapitalSpeaker
Profile
Daniel is a Principal on BroadOak’s investing team, covering the firm's life science tools portfolio, with a focus on products with cell and gene therapy applications. Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for clinical-stage biotechnology companies. Daniel currently serves on the Boards of PBS Biotech and Precision Cell Systems.
Agenda Sessions
Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies
, 2:50pmView Session